BEIJING: China's top disease control official has said the country is formally considering mixing COVID-19 vaccines as a way of further boosting vaccine efficacy.
Available data shows Chinese vaccines lag behind others including Pfizer and Moderna in terms of efficacy, but require less stringent temperature controls during storage.
Giving people doses of different vaccines is one way to improve vaccines that "don't have very high rates of protection", Gao Fu, the director of the Chinese Centers for Disease Control and Prevention, said on Saturday, without specifying whether he was referring to foreign or domestic vaccines
"Inoculation using vaccines of different technical lines is being considered," Gao told a conference in the Chinese city of Chengdu.
Gao said that taking steps to "optimise" the vaccine process including changing the number of doses and the length of time between doses was a "definite" solution to efficacy issues.
Two injections of a vaccine developed by China's Sinovac Biotech, when given shorter than three weeks apart, was 49.1% effective based on data from a Phase III trial in Brazil, below the 50% threshold set by World Health Organization, according to a paper published by Brazilian researchers on Sunday ahead of peer review.
But data from a small subgroup showed that the efficacy rate increased to 62.3% when the doses were given at intervals of three weeks and longer. The overall efficacy rate for the vaccine was slightly above 50% in the trial.
China has developed four domestic vaccines approved for public use and a fifth for smaller-scale emergency use. An official said on Saturday that the country will likely produce 3 billion doses by the end of the year.
No detailed efficacy data has been released on vaccines made by China's Sinopharm. It has said two vaccines developed by its units are 79.4% and 72.5% effective respectively, based on interim results.
Both vaccine makers have presented data on their COVID-19 vaccines indicating levels of efficacy in line with those required by WHO, a WHO panel said in March.
China has shipped millions of its vaccines abroad, and officials and state media have fiercely defended the shots while calling into question the safety and logistics capabilities of other vaccines.
"The global vaccine protection rate test data are both high and low," Gao told state tabloid Global Times on Sunday.
"How to improve the protection rate of vaccines is a problem that requires global scientists to consider," Gao said, adding that mixing vaccines and adjusting immunisation methods are solutions that he had proposed.
Gao also rejected claims by some media reports that he said Chinese COVID-19 vaccines have a low protection rate, telling Global Times that it was "a complete misunderstanding."
Reuters
Tue Apr 13 2021
Gao Fu says giving people doses of different vaccines is one way to improve vaccines that "don't have very high rates of protection. - REUTERS
Enam rakyat Vietnam ditemukan maut di sebuah hotel di Bangkok
Enam orang ditemukan maut di sebuah hotel di Bangkok, Thailand pada Selasa laporan media tempatan yang memetik polis Bangkok.
AWANI 7:45 [16/07/2024] - Suspek dibawa ke lokasi | Selamat tinggal rakyat Malaysia | Harimau Malaya hilang taring?
- Polis sahkan suspek bunuh Kartini anggota polis.
- Pan-Gon enggan dedah punca letak jawatan.
- Faisal Halim sedih mentor Pan-Gon undur diri.
- Pakai reben putih di Parlimen, tak salah.
- Pan-Gon enggan dedah punca letak jawatan.
- Faisal Halim sedih mentor Pan-Gon undur diri.
- Pakai reben putih di Parlimen, tak salah.
Najib fail permohonan di mahkamah rayuan cabar Titah Adendum
Berdasarkan sistem e-filing mahkamah, rayuan itu telah ditetapkan untuk pengurusan kes pada 7 Oktober ini.
Pangsapuri mewah bernilai RM1 juta menanti pemenang emas Olimpik
Hannah Yeoh berkata Jawatankuasa RTG telah menerima tawaran daripada pemaju hartanah, Top Residency, yang berminat untuk menghadiahkan pemenang pingat emas pertama.
E-sukan harus dijadikan kepentingan sehingga ke peringkat lebih tinggi
Kerajaan juga harus wujudkan sebuah dasar yang jelas supaya kepentingan e-sukan ini mampu diperkembangkan ke masa hadapan.
Kerajaan pandang serius penularan ideologi liberalism, pluralism
Kerajaan sentiasa memandang serius terhadap penularan ideologi dan aliran pemikiran yang bercanggah dengan ajaran Islam seperti ideologi liberalism dan pluralism agama.
Tidak dapat tidak, atlet RTG mesti bawa pulang emas - MOM
Atlet di bawah projek Road To Gold (RTG) tidak mempunyai pilihan selain memenangi emas yang diidam-idamkan Malaysia pada Sukan Olimpik 2024 di Paris.
KEDA peruntuk RM3.37 juta tahun ini bagi keterjaminan makanan
Lembaga Kemajuan Wilayah Kedah (KEDA) memperuntukkan RM3.37 juta pada tahun ini bagi memastikan keterjaminan makanan negara.
Dewan Rakyat lulus RUU Agensi Kawalan dan Perlindungan Sempadan Malaysia
Rang Undang-Undang Agensi Kawalan dan Perlindungan Sempadan Malaysia 2024 yang bertujuan menubuhkan MCBA diluluskan persidangan Dewan Rakyat, hari ini.
PAC akan mulakan prosiding isu dibangkit LKAN Siri 2/2024
Jawatankuasa Kira-Kira Wang Negara (PAC) akan memulakan prosiding bagi empat isu yang dibangkitkan dalam Laporan Ketua Audit Negara (LKAN) Siri 2/2024.
Suruhanjaya Eropah luluskan vaksin COVID-19 versi terkini
Suruhanjaya Eropah sudah meluluskan versi terkini vaksin COVID-19 yang dibangunkan oleh BioNTech-Pfizer.
Kempen MyPELINDUNG didik masyarakat terus perangi COVID-19
Meskipun Malaysia telah mencapai kemajuan ketara, namun virus COVID-19 tetap kekal sebagai satu kebimbangan kesihatan.
Puting beliung musnahkan gudang utama Pfizer
Syarikat farmaseutikal Pfizer mengesahkan bahawa kompleks tersebut telah rosak akibat puting beliung yang berlaku dekat Rocky Mount.
Belgium akan musnahkan hampir 6 juta vaksin COVID-19 yang luput
Belgium tidak boleh menggunakan lagi lebihan vaksin asli dan 2.6 juta dos Moderna dan 3.3 juta dos Pfizer akan dimusnahkan secepat mungkin.
WEF2023: Pfizer umum penjualan tanpa untung kepada negara miskin
Ini termasuk ubat luar paten, menjadikan jumlah keseluruhan produk yang ditawarkan kepada lebih 500 jenis.
Vaksin COVID-19: AS setuju cadangan dos penggalak kepada 12 tahun ke atas
CDC dijangka menerima pakai cadangan itu, sebagai langkah sebelum suntikan boleh dimulakan.
Moderna saman Pfizer, BioNTech kerana tiru paten
Moderna mendakwa, kedua-dua syarikat itu meniru teknologi yang dihasilkannya sejak sekian lama sebelum pandemik bermula.
COVID-19: Singapura beri suntikan dos penggalak kepada kanak-kanak berusia 5 hingga 11 tahun pada suku keempat
Kementerian Kesihatan sudah menerima cadangan yang dikemukakan Jawatankuasa Pakar mengenai Vaksinasi COVID-19 (EC19V).
COVID-19: Vaksin Pfizer, Moderna lulus untuk kanak-kanak 6 bulan ke 5 tahun
Dengan kelulusan ini, sekitar 18 juta kanak-kanak dalam kumpulan umur berkenaan layak untuk menerima vaksin.
PICKids: Tiada lagi vaksin Pfizer, Sinovac untuk kanak-kanak selepas 31 Mei - ProtectHealth
Sebelum ini Kementerian Kesihatan Malaysia (KKM) memutuskan untuk melanjutkan tarikh akhir pemberian vaksin PICKids dari 15 Mei kepada 31 Mei.